CNA Financial’s AbbVie ABBV Stock Holding History

CNA Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-60,000	Closed	-$9.7M	–	19
2022 Q4	$9.7M	Buy	60,000 +10,000	+20%	+$1.53M	5.9%	7
2022 Q3	$6.71M	Sell	50,000 -10,000	-17%	-$1.43M	2.55%	11
2022 Q2	$9.19M	Hold	60,000	–	–	3.21%	11
2022 Q1	$9.73M	Sell	60,000 -25,000	-29%	-$3.63M	3.02%	6
2021 Q4	$11.5M	Sell	85,000 -10,000	-11%	-$1.18M	3.01%	3
2021 Q3	$10.2M	Buy	95,000 +20,000	+27%	+$2.29M	2.79%	2
2021 Q2	$8.45M	Sell	75,000 -5,000	-6%	-$563K	2.39%	7
2021 Q1	$8.66M	Sell	80,000 -10,250	-11%	-$1.1M	2.66%	5
2020 Q4	$9.67M	Buy	90,250 +10,250	+13%	+$985K	3.04%	1
2020 Q3	$7.01M	Buy	80,000 +5,000	+7%	+$471K	2.57%	6
2020 Q2	$7.36M	Sell	75,000 -40,000	-35%	-$3.52M	2.92%	2
2020 Q1	$8.76M	Buy	+115,000	New	+$9.8M	3.69%	12

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CNA Financial's ABBV Position: Q1 2023 in Review

CNA Financial sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 60,000 shares — an estimated $9.7M sold.

CNA Financial first reported a position in ABBV in Q1 2020 and held it in 12 quarters. The position peaked at $11.5M in Q4 2021. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

CNA Financial reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
CNA Financial sold 60,000 AbbVie shares in Q1 2023, an estimated $9.7M.
CNA Financial first reported a position in AbbVie in Q1 2020 and held it in 12 quarters.
CNA Financial's AbbVie position peaked at $11.5M in Q4 2021.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on CNA Financial's 13F filing for Q1 2023, filed 11 May 2023.